Skip to content

M36.0

Billable

Dermato(poly)myositis in neoplastic disease

HCC Category Mapping

V28HCC 93Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.175
V24HCC 40Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.307
ESRDHCC 40Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.000
RxHCCHCC 83Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.000

What This Code Means

Muscle inflammation and weakness (dermatomyositis or polymyositis) that occurs as a result of cancer in the body.

Coding Tips

  • Always code the underlying neoplasm first, then this code as a secondary diagnosis
  • Document the type of cancer and which muscles are affected

Clinical Significance

Dermato(poly)myositis in neoplastic disease represents a serious paraneoplastic syndrome requiring oncologic evaluation and treatment of both the underlying malignancy and the inflammatory myopathy. This condition has high mortality risk and requires coordinated care between oncology and rheumatology.

Documentation Requirements

  • Documentation of confirmed malignancy with specific type and staging
  • Evidence of dermatomyositis or polymyositis with characteristic features
  • Muscle enzyme elevation and/or electromyographic abnormalities
  • Muscle or skin biopsy findings consistent with inflammatory myopathy
  • Timeline establishing relationship between cancer and myositis
  • Assessment of muscle weakness and functional impairment
  • Treatment plan addressing both cancer and inflammatory myopathy

Code First

Commonly Confused Codes

Code Hierarchy

Open M36.0 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.